Center for Regenerative Medicine in Barcelona, Barcelona, Spain.
Stem Cells. 2011 Aug;29(8):1186-95. doi: 10.1002/stem.672.
Gamete failure-derived infertility affects millions of people worldwide; for many patients, gamete donation by unrelated donors is the only available treatment. Embryonic stem cells (ESCs) can differentiate in vitro into germ-like cells, but they are genetically unrelated to the patient. Using an in vitro protocol that aims at recapitulating development, we have achieved, for the first time, complete differentiation of human induced pluripotent stem cells (hiPSCs) to postmeiotic cells. Unlike previous reports using human ESCs, postmeiotic cells arose without the over-expression of germline related transcription factors. Moreover, we consistently obtained haploid cells from hiPSCs of different origin (keratinocytes and cord blood), produced with a different number of transcription factors, and of both genetic sexes, suggesting the independence of our approach from the epigenetic memory of the reprogrammed somatic cells. Our work brings us closer to the production of personalized human gametes in vitro.
配子失败导致的不孕不育影响了全球数百万人;对于许多患者来说,配子捐赠是唯一可行的治疗方法。胚胎干细胞(ESCs)可以在体外分化为类配子细胞,但它们与患者在基因上没有关系。我们使用一种旨在重现发育的体外方案,首次成功地将人类诱导多能干细胞(hiPSC)完全分化为减数分裂后的细胞。与以前使用人类 ESCs 的报告不同,减数分裂后的细胞在没有过度表达生殖系相关转录因子的情况下出现。此外,我们还从不同来源(角质细胞和脐带血)的 hiPSC 中持续获得了单倍体细胞,这些细胞使用了不同数量的转录因子,并且具有不同的遗传性别,这表明我们的方法独立于重编程体细胞的表观遗传记忆。我们的工作使我们更接近于在体外生产个性化的人类配子。